Clinical trial

Trial of Progesterone in Twins and Triplets to Prevent Preterm Birth (STTARS)

NCT00099164 · The George Washington University Biostatistics Center, Other · Completed

Key facts

NCT number NCT00099164
Title Trial of Progesterone in Twins and Triplets to Prevent Preterm Birth (STTARS)
Official title A Randomized Trial of 17 Alpha-Hydroxyprogesterone Caproate for Prevention of Preterm Birth in Multifetal Gestation (STTARS)
Lead sponsor The George Washington University Biostatistics Center, Other
Collaborators Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) NIH
Status Completed
Phase Phase 3
Study type Interventional
Conditions Preterm Birth, Pregnancy, Multifetal
Intervention type Drug
Interventions 17 alpha-hydroxyprogesterone caproate (17P)
Enrollment 795
Start date Apr 1, 2004
Primary completion Aug 1, 2006
Completion Sep 1, 2007
First posted Dec 9, 2004
Last update posted Feb 21, 2019
Countries United States

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies